C-Reactive Protein: Clinical and Epidemiological Perspectives

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604

The burden of oral disease: challenges to improving oral health in the 21st century.

Petersen, P. E. (2005) · Europe PMC (PubMed Central) · Cited by 3,575

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436

MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION

PearsonT, A., MensahG, A., & AlexanderR, W. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00016 · Cited by 2,937

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B. R., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,361

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score

Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814

Lipoprotein(a) as a cardiovascular risk factor: current status

Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study

Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541

Blood Pressure as a Cardiovascular Risk Factor

Kannel, W. B. (1996) · JAMA · doi:10.1001/jama.1996.03530440051036 · Cited by 1,356

Diabetes and cardiovascular risk factors: the Framingham study

Kannel, W. B., & McGee, D. L. (1979) · Circulation · doi:10.1161/01.cir.59.1.8 · Cited by 1,317

Novel Risk Factors for Systemic Atherosclerosis

Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,290

Cholesterol and Mortality

Anderson, K. M. (1987) · JAMA · doi:10.1001/jama.257.16.2176 · Cited by 1,071

Immunity, atherosclerosis and cardiovascular disease

Frostegård, J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-117 · Cited by 1,040

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010

Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study

Cesari, M., Penninx, B. W. J. H., Newman, A. B., Kritchevsky, S. B., Nicklas, B. J., Sutton-Tyrrell, K., Rubin, S. M., Ding, J., Simonsick, E. M., Harris, T. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000097109.90783.fc · Cited by 978

Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease: A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland

Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1165 · Cited by 890

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R. (2008) · Circulation · doi:10.1161/circulationaha.108.814251 · Cited by 841

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project

Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836

Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

Vasan, R. S., SULLIVAN, L. M., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Sawyer, D. B., Levy, D. A., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 763

Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared With the Chinese Multi-provincial Cohort Study

Liu, J. (2004) · JAMA · doi:10.1001/jama.291.21.2591 · Cited by 697

Evaluation of Nine Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2

Roberts, W. L., Moulton, L., Law, T. C., Farrow, G., Cooper-Anderson, M., Savory, J., & Rifai, N. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.418 · Cited by 652

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk

Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 635

Obesity as a cardiovascular risk factor

Sowers, J. R. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.012 · Cited by 584 · cited 1×

C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force

Buckley, D., Fu, R. F., Freeman, M., Rogers, K. R., & Helfand, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00009 · Cited by 561

Racial and ethnic differences in cardiovascular disease risk factors: a systematic review.

Kurian, A. K., & Cardarelli, K. (2007) · PubMed · doi:10.13016/rsqw-ztls · Cited by 557

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristics

Kagan, A., Harris, B. R., Winkelstein, W., Johnson, K. G., Kato, H., Syme, S. L., Rhoads, G. G., Gay, M. L., Nichaman, M. Z., Hamilton, H. B., et al. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90014-9 · Cited by 548

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

Jellinger, P. S., Smith, D. A., Mehta, A., Ganda, O. P., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533

Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease; Edinburgh Artery Study Edinburgh Artery Study

Price, J. F. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1194 · Cited by 405

Coming of Age of C-Reactive Protein: Using Inflammation Markers in Cardiology

Yeh, E. T. H., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000053731.05365.5a · Cited by 403

Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population

Stec, J. J., Silbershatz, H., Tofler, G. H., Matheney, T. H., Sutherland, P. A., Lipinska, I., Massaro, J. M., Wilson, P. W. F., Muller, J. E., & D’Agostino, R. B. (2000) · Circulation · doi:10.1161/01.cir.102.14.1634 · Cited by 340

Analytical Evaluation of Particle-Enhanced Immunonephelometric Assays for C-Reactive Protein, Serum Amyloid a and Mannose-Binding Protein in Human Serum

Ledue, T. B., Weiner, D. L., Sipe, J. D., Poulin, S. E., Collins, M. F., & Rifai, N. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500607 · Cited by 321

Blood pressure as a cardiovascular risk factor: prevention and treatment

Kannel, W. B. (1996) · JAMA · doi:10.1001/jama.275.20.1571 · Cited by 309

Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors–a review.

Puddey, I. B., Rakic, V., Dimmitt, S. B., & Beilin, L. J. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9456493.x · Cited by 309

Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and Thrombomodulin

Peter, K., Nawroth, P. P., Conradt, C., Nordt, T. K., Weiss, T., Boehme, M. W. J., Wünsch, A., Allenberg, J. R., Kübler, W., & Bode, C. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.3.505 · Cited by 306

Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A. M., Rifai, N., Califf, R. M., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.106.628909 · Cited by 305

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment

Pietlla, K. O., Harmoinen, A. P. T., Jokiniitty, J. M., & Pasternack, A. I. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015068 · Cited by 263

Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients

Mueller, C. E., Buettner, H. J., Hodgson, J. M., Marsch, S. C. U., Perruchoud, A. P., Roskamm, H., & Neumann, F. (2002) · Circulation · doi:10.1161/01.cir.0000012625.02748.62 · Cited by 248

C-reactive protein is a mediator of cardiovascular disease

Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq238 · Cited by 230

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation

Ferrario, M., Chiodini, P., Chambless, L. E., Cesana, G., Vanuzzo, D., Panico, S., Sega, R., Pilotto, L., Palmieri, L., & Giampaoli, S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh405 · Cited by 214

C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease

Ridker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging Biomarkers for Primary Prevention of Cardiovascular Disease

Myers, G. L., Christenson, R. H., Cushman, M., Ballantyne, C. M., Cooper, G. R., Pfeiffer, C. M., Grundy, S. M., Labarthe, D. R., Levy, D. A., Rifai, N., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.115899 · Cited by 186

Cardiovascular risk factors: when should we treat?

Tonkin, A. M., Lim, S. S., & Schirmer, H. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05092.x · Cited by 186

C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003

Boekholdt, S. M., Hack, C. E., Sandhu, M. S., Luben, R., Bingham, S. A., Wareham, N. J., Peters, R. J. G., Jukema, J. W., Day, N., Kastelein, J. J. P., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.023 · Cited by 177

C-Reactive Protein Is a Strong but Nonspecific Risk Factor of Fatal Stroke in Elderly Persons

Gussekloo, J., Schaap, M. C. L., Frölich, M., Blauw, G. J., & Westendorp, R. G. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1047 · Cited by 159

Cholesterol and Mortality

Hainer, J. W. (1987) · JAMA · doi:10.1001/jama.1987.03400120058022 · Cited by 153

Physical inactivity as a risk factor for coronary heart disease: a WHO and International Society and Federation of Cardiology position statement.

Bijnen, F. C. H., Caspersen, C. J., & Mosterd, W. L. (1994) · Europe PMC (PubMed Central) · Cited by 150

Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses

Willeit, P., Thompson, A., Aspelund, T., Rumley, A., Eiríksdóttir, G., Lowe, G. D. O., Gudnason, V. G., & Angelantonio, E. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055175 · Cited by 112

Homocysteine: is it a clinically important cardiovascular risk factor?

Lentz, S. R., & Haynes, W. G. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.9.729 · Cited by 105

Association between Serum Interleukin-6 Concentration and Mortality in Patients with Coronary Artery Disease

Su, D., Li, Z., Li, X., Chen, Y., Zhang, Y., Ding, D., Deng, X., Xia, M., Qiu, J., & Ling, W. (2013) · Mediators of Inflammation · doi:10.1155/2013/726178 · Cited by 103

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases

Bonacina, F., Baragetti, A., Catapano, A. L., & Norata, G. D. (2013) · Mediators of Inflammation · doi:10.1155/2013/725102 · Cited by 97

A risk score predicted coronary heart disease and stroke in a Chinese cohort

Zhang, X.-F., Attia, J., D’Este, C. A., Yu, X.-H., & Wu, X. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.013 · Cited by 85

High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease

Yeh, E. T. H. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280905 · Cited by 81

C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction

Ueda, S., Ikeda, U., Yamamoto, K., Takahashi, M., Nishinaga, M., Nago, N., & Shimada, K. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90164-7 · Cited by 79

CRP is a novel ligand for the oxidized LDL receptor LOX-1

Shih, H. H., Zhang, S., Cao, W., Hahn, A., Wang, J., Paulsen, J. E., & Harnish, D. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00938.2008 · Cited by 78

C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression

Turu, M. M., SLEVIN, M. A., Matou, S., West, D. C., Rodrı́guez, C., Luque, A., Grau-Olivares, M., Badimón, L., Martínez‐González, J., & Krupiński, J. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-47 · Cited by 73

Identifying novel biomarkers for cardiovascular disease risk prediction

Ge, Y., & Wang, T. J. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02589.x · Cited by 71

C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?

Hingorani, A. D., Shah, T., Casas, J. P., Humphries, S. E., & Talmud, P. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.115923 · Cited by 70

C-reactive protein improves risk prediction in patients with acute coronary syndromes

Schiele, F., Meneveau, N., Seronde, M., Chopard, R., Descotes‐Genon, V., Dutheil, J., Bassand, J., & Comte', O. B. O. T. '. D. C. D. F. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp273 · Cited by 68

Section 34 : some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements

Cupples, L. A. (1987) · Medical Entomology and Zoology · Cited by 64

Level of C-Reactive Protein as a Measure of Acute Myocardial Infarction.

Kroop, I. G., & Shackman, N. H. (1954) · Experimental Biology and Medicine · doi:10.3181/00379727-86-21019 · Cited by 54

Assessing coronary heart disease risk with traditional and novel risk factors

Wilson, P. W. F. (2004) · Clinical Cardiology · doi:10.1002/clc.4960271504 · Cited by 48

Metabolic biomarkers for predicting cardiovascular disease

Brown, J. R., & Montgomery (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s30378 · Cited by 42

[Estimation of coronary heart disease risk in Chilean subjects based on adapted Framingham equations].

Icaza, G., Núñez, L., Marrugat, J., Mujica, V., Escobar, M. C., Jiménez, A. L., Pérez, P., & Palomo, I. F. (2009) · PubMed · Cited by 42

Trends in C-Reactive Protein Levels in US Adults From 1999 to 2010

Ong, K. L., Allison, M., Cheung, B. M. Y., Wu, B. J., Barter, P. J., & Rye, K. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws443 · Cited by 41

C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care

Ridker, P. M., Kastelein, J. J. P., Genest, J. J., & Köenig, W. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht022 · Cited by 39

Proteína C reactiva y su relación con adiposidad, factores de riesgo cardiovascular y aterosclerosis subclínica en niños sanos

Mónica Acevedo, B., Arnaíz, P., Salesa Barja, Y., Claudia Bambs, S., Berrios, X., Guzmán, B., Carvajal, J., Cassis, B., & Navarrete, C. (2007) · Revista Española de Cardiología · doi:10.1157/13111237 · Cited by 37

The Inflammatory Hypothesis

Blankenberg, S., & Yusuf, S. (2006) · Circulation · doi:10.1161/circulationaha.106.652081 · Cited by 33

Should C-Reactive Protein Be a Target of Therapy?

Oh, J., Teoh, H., & Leiter, L. A. (2011) · Diabetes Care · doi:10.2337/dc11-s211 · Cited by 30

Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial

Caixeta, A. M., Stone, G. W., Mehran, R., Lee, E. A., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., White, H. D., et al. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0516-y · Cited by 29

Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population

Razavi, A., Baghshani, M. R., Rahsepar, A. A., Ardabili, H. M., Andalibi, M. S. S., Parizadeh, S. M. R., Tavallaie, S., Mousavi, S., Ghayour‐Mobarhan, M., & Ferns, G. A. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012104 · Cited by 25

046 C-Reactive Protein Improves Risk Prediction in Patients with Acute Coronary Syndromes

Schiele, F., Meneveau, N. F., Seronde, M., Descotes‐Genon, V., Chopard, R., Oettinger, J., Guignier, A., Briand, F., & Bassand, J. (2010) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(10)70048-3 · Cited by 21

Association of high sensitive C-reactive protein (hsCRP) with established cardiovascular risk factors in the Indian population

Jeemon, P., Prabhakaran, D., Ramakrishnan, L., Gupta, R., Ahmed, F., Thankappan, K. R., Kartha, C. S., Chaturvedi, V., Reddy, K. S., & the Sentinel Surveillance in Industrial Populations Study Group (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-19 · Cited by 19

Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?~!2009-11-07~!2009-12-10~!2010-02-22~!

Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020038 · Cited by 17

Concentraciones de proteína C reactiva en adultos mexicanos: alta prevalencia de un factor de riesgo cardiovascular

Flores, M., Barquera, S., Carrión, C., Rojas, R., Villalpando, S., Olaiz-Fernández, G., & González‐Villalpando, C. (2007) · Salud Pública de México · doi:10.1590/s0036-36342007000900006 · Cited by 14

Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Kraus, V. B., & Jordan, J. M. (2007) · PubMed Central · Cited by 14

Cardiovascular high-risk patients--treat to protect, but whom?

Zannad, F. M., Jakobsen, A., Heroys, J., Ralph, A., Rees, T., & Shaw, M. (2008) · PubMed · Cited by 13

Adiponectina, un factor de riesgo cardiovascular emergente. Estudio REFERENCE

Barrios, V., Gómez‐Huelgas, R., Rodríguez, R., & de Pablos-Velasco, P. L. (2008) · Revista Española de Cardiología · doi:10.1157/13127847 · Cited by 12

Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors

Ge, Y., Cheng, S. C., Larson, M. G., Ghorbani, A., Martin, R. P., Klein, R. J., O’Donnell, C. J., Vasan, R. S., Shaw, S. Y., Wang, T. J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.017 · Cited by 11

Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?

Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010038 · Cited by 11

Enfermedad cardiovascular aterosclerótica: la utilidad de la proteína C reactiva en la identificación de la placa «vulnerable» y del paciente «vulnerable»

Arroyo‐Espliguero, R., y, P. A., & Kaski, J. C. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77120-1 · Cited by 11

Triglycerides and cardiovascular risk

Jones, A. F. (2012) · Heart · doi:10.1136/heartjnl-2012-302968 · Cited by 10

Delayed Treatment of Papillary Thyroid Carcinoma Arising from Struma Ovarii in a Patient with History of Bilateral Salpingo-Oophorectomy: A Case Report

Collins, A. M., Bodenner, D., Chen, C., Stone, P. J. B., & Stack, B. C. (2011) · Endocrine Practice · doi:10.4158/ep11253.cr · Cited by 10

Apolipoproteínas B e A-I: fatores de risco cardiovascular?

Forti, N. A., & Diament, J. (2007) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302007000300029 · Cited by 10

Adiponectin: An Emerging Cardiovascular Risk Factor. The REFERENCE Study

Barrios, V., Gómez‐Huelgas, R., Rodríguez, R., & de Pablos-Velasco, P. L. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)60030-x · Cited by 9

THE VALUE OF THE C-REACTIVE PROTEIN DETERMINATION IN CORONARY ARTERY DISEASE

KOZONIS, M. C., & GUREVIN, I. (1957) · Annals of Internal Medicine · doi:10.7326/0003-4819-46-1-79 · Cited by 8

La proteína C reactiva como blanco terapéutico en la prevención cardiovascular: ¿ficción o realidad?

Heres-Álvarez, F. D. L. C., & Peix-González, A. T. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)15006-2 · Cited by 7

C-Reactive Protein in Acute Coronary Syndrome. Looking Back in Order to Move Forward

Bodı́, V., & Sanchís, J. M. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60789-5 · Cited by 6

Coronary Risk Estimation According to the Framingham-Wilson Score: Epidemiologic Behavior of Innovative Cardio Metabolic Risk Factors in the Maracaibo City

Rojas, E. (2013) · International Journal of Cardiovascular Research · doi:10.4172/2324-8602.1000136 · Cited by 5

Papel de la proteína C reactiva en las enfermedades cardiovasculares

Manzur, F., Alvear, C., & Alayón, A. N. (2011) · Revista Colombiana de Cardiología · doi:10.1016/s0120-5633(11)70198-x · Cited by 5

Atherosclerotic Coronary Artery Disease: Usefulness of C-Reactive Protein for the Identification of the “Vulnerable” Plaque and the “Vulnerable” Patient

Arroyo‐Espliguero, R., y, P. A., & Kaski, J. C. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60166-7 · Cited by 5

La proteína C reactiva en el síndrome coronario agudo. Una mirada atrás para seguir avanzando

Bodı́, V., & Sanchís, J. M. (2006) · Revista Española de Cardiología · doi:10.1157/13087893 · Cited by 5

Family history—and independent risk factors for coronary heart disease, it is time to be practical

Šimon, J. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3295 · Cited by 4

C-Reactive Protein in the Emergency Department: Has It Found a Clinical Application?

Kaski, J. C., & Fernandez-Berges, D. J. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60022-5 · Cited by 4

Proteína C reactiva en el servicio de urgencias: ¿ha encontrado una aplicación clínica?

Kaski, J. C., & Fernandez-Berges, D. J. (2007) · Revista Española de Cardiología · doi:10.1157/13108992 · Cited by 4

Mas allá de la prevención primaria: utilidad de la proteína C reactiva ultra sensible (PCRus), como herramienta en el diagnóstico de enfermedad arterial coronaria

Maiorana, C., Duque, J., Pellino, M. L., Tovar, S. S., Lares, M., Castillo, C. D. P., & Jiménez, A. (2011) · Cited by 3

C-reactive protein as a prognostic tool in cardiovascular practices: should CRP testing be ordered along with lipid profiles?

van der Bom, J. G., & Cramer, M. J. (2003) · PubMed Central · Cited by 2

Family history—and independent risk factors for coronary heart disease, it is time to be practical

Simon, J. (2002) · European Heart Journal · doi:10.1016/s0195-668x(02)93295-1 · Cited by 2

[Global cardiovascular risk: definition, evaluation and management strategies. Round table no. 1. XV].

Amouyel, P., & Blanchet‐Deverly, A. (2000) · PubMed · Cited by 2

Proteína C reactiva (PCR) y ateroesclerosis

Ferrer, J. I. (2005) · Revista CENIC. Ciencias biológicas · Cited by 1

Proteína C Reactiva en el pronóstico de la insuficiencia cardiaca

Figueroa, P. R., Hamad, I., García, F. J. P., Marín, A. F. C., Almeida, M. A. C., & Forcada, A. G. (2007) · Revista Costarricense de Cardiología · Cited by 1

Obesity and female infertility: potential mediators of obesity's impact

Broughton, D. E., & Moley, K. H. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.017 · Cited by 845

Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.

Oguntibeju, O. O. (2019) · Europe PMC (PubMed Central) · Cited by 758

Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke

Esenwa, C. C., & Elkind, M. S. V. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.125 · Cited by 285

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Kandelouei, T., Abbasifard, M., Imani, D., Aslani, S., Razi, B., Fasihi, M., Shafiekhani, S., Mohammadi, K., Jamialahmadi, T., Reiner, Ž., et al. (2022) · Mediators of Inflammation · doi:10.1155/2022/8732360 · Cited by 136

Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study

Metcalf, S. A., Jones, P. B., Nordström, T., Timonen, M., Mäki, P. H., Miettunen, J., Jääskeläinen, E., Järvelin, M., Štochl, J., Murray, G. K., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.008 · Cited by 124

Review Article C-Reactive Protein: Clinical and Epidemiological Perspectives

Silva, C., Rojas, J., & Bermúdez, V. (2016)

C-reactive protein comes of age

Verma, S., Szmitko, P. E., & Ridker, P. M. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0074 · Cited by 211

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events

Torres, J. L., & Ridker, P. M. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200311000-00008 · Cited by 101

Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practice.

Zebrack, J., & Anderson, J. L. (2002) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2002.1118.x · Cited by 28

C-reactive protein: a nontraditional serum marker of cardiovascular risk

de Ferranti, S. D., & Rifai, N. (2007) · Cardiovascular Pathology · doi:10.1016/j.carpath.2006.04.006 · Cited by 185